… (brand name Dynacirc CR), a drug currently approved to treat high blood pressure, was awarded Blue Ribbon status for work … disease-modifying effect. This work is still to come, and will depend on a more robust potential clinical …

… Study Rationale: Previous research has shown higher levels of the c-Abl … Parkinson's disease (PD), and studies have linked c-Abl to pathways associated with the disease. Impeding the … the drug doses appears to be the maximum tolerated. If outcomes provide conclusive safety data, a second funded trial …

… The drug development pipeline is key to bringing new therapies to people with Parkinson’s disease … head of the Parkinson’s Disease and Movement Disorders Center at Northwestern University. She is also the leader of … a PPMI site and part of the initiative’s executive steering committee.  Rick Grant is a PPMI participant who was …

… Artist Frank Ferraro compares his Parkinson’s disease to having his left leg is nailed to the floor, forcing him … who they are as a person,” Caruso says. The piece aims to express that while the “left leg” may be immobilized, the …

… video, our on-staff movement disorder specialist and Vice President of Medical Communications, Rachel Dolhun, MD, discusses dystonia: painful muscle cramps that can cause abnormal body …

… Yes, I have included MJFF in my estate plans No, but I plan to include MJFF in my estate plans Please send me more information No/ I prefer not to answer   Continue Thank you for your … had PD I am a researcher, clinician or work with the PD community Other   Diagnosis Date ${selected} Jan Feb Mar Apr …